Lee Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-60
| Closed | -$3.76K | – | 298 |
|
|
2023
Q4 | $3.76K | Hold |
60
| – | – | ﹤0.01% | 602 |
|
|
2023
Q3 | $2.72K | Hold |
60
| – | – | ﹤0.01% | 621 |
|
|
2023
Q2 | $3.37K | Hold |
60
| – | – | ﹤0.01% | 563 |
|
|
2023
Q1 | $2.71K | Hold |
60
| – | – | ﹤0.01% | 616 |
|
|
2022
Q4 | $2.44K | Hold |
60
| – | – | ﹤0.01% | 656 |
|
|
2022
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 564 |
|
|
2022
Q2 | $4K | Hold |
60
| – | – | ﹤0.01% | 579 |
|
|
2022
Q1 | $4K | Hold |
60
| – | – | ﹤0.01% | 528 |
|
|
2021
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 590 |
|
|
2021
Q3 | $7K | Hold |
60
| – | – | ﹤0.01% | 459 |
|
|
2021
Q2 | $10K | Hold |
60
| – | – | ﹤0.01% | 407 |
|
|
2021
Q1 | $7K | Hold |
60
| – | – | ﹤0.01% | 418 |
|
|
2020
Q4 | $9K | Sell |
60
-720
| -92% | -$108K | ﹤0.01% | 384 |
|
|
2020
Q3 | $65K | Hold |
780
| – | – | 0.02% | 195 |
|
|
2020
Q2 | $57K | Buy |
780
+720
| +1,200% | +$52.6K | 0.02% | 188 |
|
|
2020
Q1 | $3K | Hold |
60
| – | – | ﹤0.01% | 404 |
|
|
2019
Q4 | $4K | Hold |
60
| – | – | ﹤0.01% | 425 |
|
|
2019
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 475 |
|
|
2019
Q2 | $3K | Hold |
60
| – | – | ﹤0.01% | 453 |
|
|
2019
Q1 | $2K | Hold |
60
| – | – | ﹤0.01% | 468 |
|
|
2018
Q4 | $2K | Hold |
60
| – | – | ﹤0.01% | 412 |
|
|
2018
Q3 | $3K | Hold |
60
| – | – | ﹤0.01% | 435 |
|
|
2018
Q2 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 640 |
|